These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 11781070

  • 1. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T, Nishioka K.
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [Abstract] [Full Text] [Related]

  • 2. Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma.
    Yamamoto T, Takagawa S, Katayama I, Nishioka K.
    Clin Immunol; 1999 Jul; 92(1):6-13. PubMed ID: 10413648
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor both prevents and ameliorates the symptoms of dermal sclerosis in a mouse model of scleroderma.
    Wu MH, Yokozeki H, Takagawa S, Yamamoto T, Satoh T, Kaneda Y, Katayama I, Nishioka K.
    Gene Ther; 2004 Jan; 11(2):170-80. PubMed ID: 14712301
    [Abstract] [Full Text] [Related]

  • 4. Increased expression of TGF-beta1 in the sclerotic skin in bleomycin-'susceptible' mouse strains.
    Oi M, Yamamoto T, Nishioka K.
    J Med Dent Sci; 2004 Mar; 51(1):7-17. PubMed ID: 15137460
    [Abstract] [Full Text] [Related]

  • 5. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T, Takahashi Y, Takagawa S, Katayama I, Nishioka K.
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
    Kohno S, Endo H, Hashimoto A, Hayashi I, Murakami Y, Kitasato H, Kojima F, Kawai S, Kondo H.
    Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
    [Abstract] [Full Text] [Related]

  • 7. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A, Korn JH.
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of etanercept in bleomycin-induced experimental scleroderma.
    Koca SS, Isik A, Ozercan IH, Ustundag B, Evren B, Metin K.
    Rheumatology (Oxford); 2008 Feb; 47(2):172-5. PubMed ID: 18174229
    [Abstract] [Full Text] [Related]

  • 9. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J.
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of p53 and p21 (Waf1/Cip1) in the lesional skin of bleomycin-induced scleroderma.
    Yamamoto T, Nishioka K.
    Arch Dermatol Res; 2005 May; 296(11):509-13. PubMed ID: 15803328
    [Abstract] [Full Text] [Related]

  • 11. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M, McCann M, Liu S, Huh K, Denton CP, Abraham DJ, Leask A.
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [Abstract] [Full Text] [Related]

  • 12. Investigation of sensory neurogenic components in a bleomycin-induced scleroderma model using transient receptor potential vanilloid 1 receptor- and calcitonin gene-related peptide-knockout mice.
    Szabó A, Czirják L, Sándor Z, Helyes Z, László T, Elekes K, Czömpöly T, Starr A, Brain S, Szolcsányi J, Pintér E.
    Arthritis Rheum; 2008 Jan; 58(1):292-301. PubMed ID: 18163477
    [Abstract] [Full Text] [Related]

  • 13. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 14. Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model.
    Liu S, Kapoor M, Denton CP, Abraham DJ, Leask A.
    Arthritis Rheum; 2009 Sep; 60(9):2817-21. PubMed ID: 19714619
    [Abstract] [Full Text] [Related]

  • 15. Basic fibroblast growth factor induces down-regulation of alpha-smooth muscle actin and reduction of myofibroblast areas in open skin wounds.
    Ishiguro S, Akasaka Y, Kiguchi H, Suzuki T, Imaizumi R, Ishikawa Y, Ito K, Ishii T.
    Wound Repair Regen; 2009 Sep; 17(4):617-25. PubMed ID: 19614927
    [Abstract] [Full Text] [Related]

  • 16. [Expression of alpha-smooth muscle actin in scar fibroblasts in vitro].
    Huang H, Tang SJ, Bao WH.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Nov; 15(6):347-50. PubMed ID: 11762220
    [Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma.
    Matsushita M, Yamamoto T, Nishioka K.
    Clin Exp Immunol; 2005 Mar; 139(3):429-38. PubMed ID: 15730388
    [Abstract] [Full Text] [Related]

  • 18. Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective.
    Yamamoto T, Nishioka K.
    Exp Dermatol; 2005 Feb; 14(2):81-95. PubMed ID: 15679577
    [Abstract] [Full Text] [Related]

  • 19. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin.
    Hayashi S, Ikeda M, Kitamura Y, Hamasaki Y, Hatamochi A.
    J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844
    [Abstract] [Full Text] [Related]

  • 20. Local injection of latency-associated peptide, a linker propeptide specific for active form of transforming growth factor-beta1, inhibits dermal sclerosis in bleomycin-induced murine scleroderma.
    Nakamura-Wakatsuki T, Oyama N, Yamamoto T.
    Exp Dermatol; 2012 Mar; 21(3):189-94. PubMed ID: 22188586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.